Maki Komiyama

Kyoto, 6128555, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 65 publications

Lipid-lowering therapy: Evidence and future perspective.

Lipid-lowering therapy: Evidence and future perspective.

Journal: JRSM cardiovascular disease

Published: March 05, 2026

Immunoglobulin free light chain-κ in association with NT-proBNP levels after smoking cessation.

Immunoglobulin free light chain-κ in association with NT-proBNP levels after smoking cessation.

Journal: Future science OA

Published: September 07, 2025

The citrus flavonoid nobiletin prevents the development of doxorubicin-induced heart failure by inhibiting apoptosis.

The citrus flavonoid nobiletin prevents the development of doxorubicin-induced heart failure by inhibiting apoptosis.

Journal: Journal of pharmacological sciences

Published: October 29, 2024

Will mineralocorticoid receptor antagonists give impact on HFpEF pharmacotherapy in addition to SGLT2 inhibitors?

Will mineralocorticoid receptor antagonists give impact on HFpEF pharmacotherapy in addition to SGLT2 inhibitors?

Journal: European heart journal. Cardiovascular pharmacotherapy

Published: October 07, 2024

Efficacy of highly bioavailable oral curcumin in asymptomatic or mild COVID-19 patients: a double-blind, randomized, placebo-controlled trial.

Efficacy of highly bioavailable oral curcumin in asymptomatic or mild COVID-19 patients: a double-blind, randomized, placebo-controlled trial.

Journal: Journal of health, population, and nutrition

Published: April 25, 2024

A Complex Interplay: Navigating the Crossroads of Tobacco Use, Cardiovascular Disease, and the COVID-19 Pandemic: A WHF Policy Brief.

A Complex Interplay: Navigating the Crossroads of Tobacco Use, Cardiovascular Disease, and the COVID-19 Pandemic: A WHF Policy Brief.

Journal: Global heart

Published: February 07, 2024

Anserine, a Histidine-Containing Dipeptide, Suppresses Pressure Overload-Induced Systolic Dysfunction by Inhibiting Histone Acetyltransferase Activity of p300 in Mice.

Anserine, a Histidine-Containing Dipeptide, Suppresses Pressure Overload-Induced Systolic Dysfunction by Inhibiting Histone Acetyltransferase Activity of p300 in Mice.

Journal: International journal of molecular sciences

Published: January 12, 2024

What is the Future Position of Factor XIa Inhibitors for Patients with Atrial Fibrillation?

What is the Future Position of Factor XIa Inhibitors for Patients with Atrial Fibrillation?

Journal: European cardiology

Published: December 11, 2023

World Heart Federation Roadmap for Secondary Prevention of Cardiovascular Disease: 2023 Update.

World Heart Federation Roadmap for Secondary Prevention of Cardiovascular Disease: 2023 Update.

Journal: Global heart

Published: November 09, 2023

Impact of smoking initiation age on nicotine dependency and cardiovascular risk factors: a retrospective cohort study in Japan.

Impact of smoking initiation age on nicotine dependency and cardiovascular risk factors: a retrospective cohort study in Japan.

Journal: European heart journal open

Published: September 04, 2023

Randomised Double-blind Placebo-Controlled Multicentre Trial for the Effects of Yokukansan in Smokers with Depressive Tendencies.

Randomised Double-blind Placebo-Controlled Multicentre Trial for the Effects of Yokukansan in Smokers with Depressive Tendencies.

Journal: European cardiology

Published: July 05, 2023

Triglycerides revisited: is hypertriglyceridaemia a necessary therapeutic target in cardiovascular disease?

Triglycerides revisited: is hypertriglyceridaemia a necessary therapeutic target in cardiovascular disease?

Journal: European heart journal. Cardiovascular pharmacotherapy

Published: April 04, 2023

Showing 1-12 of 65

Last Updated: 09/26/2026